Cervical Cancer
Concurrent paclitaxel/carboplatin regimen is effective for local control after hysterectomy
Published in Cancer Weekly, August 1st, 2006
Scientists in South Korea conducted a study "to evaluate the efficacy and safety of concurrent chemoradiotherapy with paclitaxel and carboplatin after hysterectomy for early stage uterine cervical carcinoma with high risk factors."
"Between March 2000 and July 2002, 37 patients with stages IB-IIB uterine cervical carcinoma were treated with radical hysterectomy and bilateral pelvic lymph node dissection followed by concurrent chemoradiotherapy (POCCRT) with two courses of paclitaxel (135 mg/m2) and carboplatin (area under the time-concentration...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-08-01)
More Articles from Cancer Weekly
- Astrocytomas
Astrocytoma cell malignancy predicted with proton magnetic resonance spectroscopy - Multiple Myeloma
Multiple myelomas malignant transformation linked to increase of functional regulatory T cells - Renal Cell Carcinoma
Renal cell carcinoma recurrence risk not impacted by width of resection margin - Acute Lymphoblastic Leukemia
GSK files for European marketing approval for Atriance as treatment for rare leukemia and lymphoma - Acute Myeloid Leukemia
New survival data on Evoltra (clofarabine) in elderly leukemia patients reported - Adenoid Cystic Cancer
Adenoid cystic carcinoma of the sinonasal tract treatments are reviewed - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
